These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9114052)

  • 1. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
    Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration.
    Wilson CB; Embree LJ; Schowalter D; Albert R; Aruffo A; Hollenbaugh D; Linsley P; Kay MA
    J Virol; 1998 Sep; 72(9):7542-50. PubMed ID: 9696851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
    Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
    Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
    J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration.
    Kay MA; Holterman AX; Meuse L; Gown A; Ochs HD; Linsley PS; Wilson CB
    Nat Genet; 1995 Oct; 11(2):191-7. PubMed ID: 7550348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
    Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
    J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
    Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
    Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.
    Halbert CL; Standaert TA; Wilson CB; Miller AD
    J Virol; 1998 Dec; 72(12):9795-805. PubMed ID: 9811715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus.
    Wang X; Huang W; Mihara M; Sinha J; Davidson A
    J Immunol; 2002 Feb; 168(4):2046-53. PubMed ID: 11823542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene.
    Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Tamura A; Suzuki K; Amemiya H; Hayashi S; Kazui T; Suzuki S
    Transplantation; 1999 Sep; 68(6):758-66. PubMed ID: 10515375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft.
    Hayashi S; Guang-Lin M; Yokoyama I; Namii Y; Hamada H; Nakao A
    Transpl Int; 2000; 13 Suppl 1():S329-32. PubMed ID: 11112025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig.
    Guérette B; Vilquin JT; Gingras M; Gravel C; Wood KJ; Tremblay JP
    Hum Gene Ther; 1996 Aug; 7(12):1455-63. PubMed ID: 8844205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG.
    Nakagawa I; Murakami M; Ijima K; Chikuma S; Saito I; Kanegae Y; Ishikura H; Yoshiki T; Okamoto H; Kitabatake A; Uede T
    Hum Gene Ther; 1998 Aug; 9(12):1739-45. PubMed ID: 9721084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-immunomodulating myoblast cell line for erythropoietin delivery.
    Schneider BL; Peduto G; Aebischer P
    Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation.
    Hayashi S; Leu D; Yamii Y; Mei G; Takagi H; Nakao A
    Transplantation; 2005 Aug; 80(4):494-9. PubMed ID: 16123724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
    Takayama T; Morelli AE; Robbins PD; Tahara H; Thomson AW
    Gene Ther; 2000 Aug; 7(15):1265-73. PubMed ID: 10918497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand.
    Tang A; Judge TA; Nickoloff BJ; Turka LA
    J Immunol; 1996 Jul; 157(1):117-25. PubMed ID: 8683104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.